IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 45,250
-2,250 (-4.74%)
At close: Feb 6, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 679.29 billion as of February 6, 2026.
Market Cap
679.29B
Enterprise Value
659.07B
Revenue
1.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
45,250.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 679.29B, an increase of 37.98%. That is a compound annual growth rate of 57.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 679.29B | -21.11% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qurient | 1.31T |
| AbClon | 1.18T |
| JS Link | 952.68B |
| Inventage Lab | 884.23B |
| ROKIT Healthcare | 816.74B |
| Curocell | 686.79B |
| HansBiomed | 548.08B |
| ToolGen | 488.11B |